Lv71
4460 积分 2024-02-04 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
12天前
已完结
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
12天前
已完结
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
12天前
已关闭
Overall Survival with Abemaciclib in Early Breast Cancer
23天前
已关闭
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
27天前
已完结
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
27天前
已完结
中国晚期乳腺癌规范诊疗指南（2024版）
27天前
已关闭
中国晚期乳腺癌规范诊疗指南（2024版）
27天前
已关闭
Cyclin-dependent kinase 4/6 inhibitor-associated pulmonary toxicity: a disproportionality analysis from 2015 to 2023 based on the FAERS database
28天前
已完结
Tailoring Treatment to Cancer Risk and Patient Preference: The 2025 St Gallen International Breast Cancer Consensus Statement on Individualizing Therapy for Patients With Early Breast Cancer
1个月前
已完结
皖公网安备34019202002308
